Miriam Goebel1, Andreas Stengel, Lixin Wang, Joseph Reeve, Yvette Taché. 1. CURE/Digestive Diseases Research Center, Center for Neurobiology of Stress, Department of Medicine, David Geffen School of Medicine, UCLA, and VA Greater Los Angeles Healthcare System, CA, USA.
Abstract
BACKGROUND: Corticotropin-releasing hormone (CRH) is expressed in the brain, immune cells and the gut, where gene expression is upregulated by lipopolysaccharide (LPS) 6 h after injection. Whether these changes are reflected by increased circulating levels of CRH and adrenocorticotropic hormone (ACTH) is unknown. METHODS: LPS (100 μg/kg) was injected intraperitoneally in conscious rats, and blood processed for CRH using the new RAPID (reduced temperatures, acidification, protease inhibition, isotopic exogenous controls and dilution) method compared with EDTA blood with or without plasma methanol extraction. Hormone levels were measured by commercial radioimmunoassay. RESULTS: The RAPID method improved blood recovery of ¹²⁵I-CRH in vitro compared to EDTA only added to the blood without or with methanol extraction (90.8 ± 2.0 vs. 66.9 ± 2.6 and 47.5 ± 2.0%, respectively; p < 0.001 vs. RAPID). Basal CRH levels from blood processed by the RAPID method were 28.9 ± 2.8 pg/ml, and by other methods below the radioimmunoassay detection limit (<10 pg/ml). At 6 h after LPS, CRH plasma levels increased significantly by 2.9 times, and in the proximal colon tended to decrease (-27.6 ± 5.7%; p > 0.05), while circulating levels were unchanged at 3 or 4 h. ACTH levels rose compared to control rats (135.3 ± 13.8 vs. 101.4 ± 6.0 pg/ml; p < 0.05) 30 min after the increase in CRH, while at 3 or 6 h after LPS, the levels were not changed. CONCLUSION: Intraperitoneal LPS induces a delayed rise in plasma CRH levels associated with an elevation in ACTH plasma levels 30 min later, suggesting that under conditions of immune challenge, CRH of peripheral origin may also contribute to pituitary activation, as detected using the RAPID method of blood processing, which improves CRH recovery.
BACKGROUND:Corticotropin-releasing hormone (CRH) is expressed in the brain, immune cells and the gut, where gene expression is upregulated by lipopolysaccharide (LPS) 6 h after injection. Whether these changes are reflected by increased circulating levels of CRH and adrenocorticotropic hormone (ACTH) is unknown. METHODS:LPS (100 μg/kg) was injected intraperitoneally in conscious rats, and blood processed for CRH using the new RAPID (reduced temperatures, acidification, protease inhibition, isotopic exogenous controls and dilution) method compared with EDTA blood with or without plasma methanol extraction. Hormone levels were measured by commercial radioimmunoassay. RESULTS: The RAPID method improved blood recovery of ¹²⁵I-CRH in vitro compared to EDTA only added to the blood without or with methanol extraction (90.8 ± 2.0 vs. 66.9 ± 2.6 and 47.5 ± 2.0%, respectively; p < 0.001 vs. RAPID). Basal CRH levels from blood processed by the RAPID method were 28.9 ± 2.8 pg/ml, and by other methods below the radioimmunoassay detection limit (<10 pg/ml). At 6 h after LPS, CRH plasma levels increased significantly by 2.9 times, and in the proximal colon tended to decrease (-27.6 ± 5.7%; p > 0.05), while circulating levels were unchanged at 3 or 4 h. ACTH levels rose compared to control rats (135.3 ± 13.8 vs. 101.4 ± 6.0 pg/ml; p < 0.05) 30 min after the increase in CRH, while at 3 or 6 h after LPS, the levels were not changed. CONCLUSION: Intraperitoneal LPS induces a delayed rise in plasma CRH levels associated with an elevation in ACTH plasma levels 30 min later, suggesting that under conditions of immune challenge, CRH of peripheral origin may also contribute to pituitary activation, as detected using the RAPID method of blood processing, which improves CRH recovery.
Authors: Joseph R Reeve; Gary M Green; Peter Chew; Viktor E Eysselein; David A Keire Journal: Am J Physiol Gastrointest Liver Physiol Date: 2003-04-09 Impact factor: 4.052
Authors: I Ahmed; B P Glynn; A V Perkins; M G Castro; J Rowe; E Morrison; E A Linton Journal: J Clin Endocrinol Metab Date: 2000-02 Impact factor: 5.958
Authors: Héctor Núñez; Samuel Ruiz; Rubén Soto-Moyano; Mario Navarrete; Luis Valladares; Allan White; Hernán Pérez Journal: Neurosci Lett Date: 2008-10-08 Impact factor: 3.046
Authors: Philippe Leff-Gelman; Ismael Mancilla-Herrera; Mónica Flores-Ramos; Carlos Cruz-Fuentes; Juan Pablo Reyes-Grajeda; María Del Pilar García-Cuétara; Marielle Danitza Bugnot-Pérez; David Ellioth Pulido-Ascencio Journal: Neurosci Bull Date: 2016-07-18 Impact factor: 5.203
Authors: Pauline Teuffel; Miriam Goebel-Stengel; Tobias Hofmann; Philip Prinz; Sophie Scharner; Jan L Körner; Carsten Grötzinger; Matthias Rose; Burghard F Klapp; Andreas Stengel Journal: J Vis Exp Date: 2016-04-28 Impact factor: 1.355
Authors: Christopher E Stamper; Patrick A Hennessey; Matthew W Hale; Jodi L Lukkes; Nina C Donner; Kenneth R Lowe; Evan D Paul; Robert L Spencer; Kenneth J Renner; Miles Orchinik; Christopher A Lowry Journal: Stress Date: 2015-02-17 Impact factor: 3.493
Authors: F P Varodayan; S Khom; R R Patel; M Q Steinman; D M Hedges; C S Oleata; G E Homanics; M Roberto; M Bajo Journal: Alcohol Alcohol Date: 2018-11-01 Impact factor: 2.826